The study aim was to evaluate the relation between the Framingham risk score (FRS) and the presence of coronary risk factors to coronary microcirculatory vasodilator function in patients with early coronary atherosclerosis.
Introduction
Atherosclerosis and coronary heart disease (CHD) are the leading causes of morbidity and mortality in developed countries. 1 Conventional risk factors for the development of CHD were defined by investigators from Framingham, MA, almost 50 years ago, 2 and were later codified into global risk scores. 3, 4 The aim of the more global cardiovascular risk assessment was to match the intensity of treatment with the level of risk. However, despite the established utility of the Framingham risk score (FRS), it may have limitation in certain patient populations such as young adults and women, and its applicability in the early stages of coronary atherosclerosis is unclear. 5 -8 The importance of identifying these patients is underscored by the observations that the majority of acute coronary syndromes occurs in nonobstructive coronary atherosclerotic (vulnerable) plaques, and it is possible that the coronary microcirculatory function may have an important role in the early stages of the disease. 9, 10 Assessment of coronary microcirculatory vasomotor function and endothelial function in patients without obstructive coronary artery disease may allow the identification of patients in the early stages of coronary atherosclerosis and at risk for cardiovascular events. 11 -15 The concept that endothelial and microvascular dysfunctions are found in patients at risk for cardiovascular disease and may be precursors for the development of atherosclerosis has been described previously. 16 -18 Therefore, the current study was designed to test the hypothesis that there are functional abnormalities at the level of coronary microcirculation in humans at the early stage of coronary atherosclerosis (including patients with a low to intermediate FRS, ,20% 10-year CHD risk).
Methods

Patient selection
The study was approved by the Mayo Clinic Institutional Review Board, and informed consent was obtained from all participants. 4 Additional measurements related to coronary risk also evaluated were: vascular disease (peripheral vascular narrowing diagnosed by physical examination and confirmed by an imaging test), mean arterial pressure (pre-procedure) at baseline, the body mass index (BMI), estimated glomerular filtration rate (eGFR) (using the MDRD formula), lipid profile, fasting glucose, and glycosylated haemoglobin. The homeostasis model assessment (HOMA) was used to estimate insulin sensitivity [calculated as (fasting glucose Â 0.0555 Â plasma insulin) /22.5] . Blood samples were also tested for highly sensitive C-reactive protein (hsCRP), plasma homocysteine, L-arginine and the plasma brain natriuretic protein (BNP).
Assessment of coronary vasomotor function
After diagnostic coronary angiography and exclusion of significant obstructive coronary artery disease (and if vasoactive medications were discontinued .48 h), coronary vasoreactivity was assessed as described previously. 13,19 -21 Intracoronary bolus injections of incremental doses (18 -60 mcg) of adenosine were administered until maximal hyperaemia was achieved (or the highest dose was given) to evaluate endothelium-independent microvascular coronary flow reserve (CFR). Subsequently, to assess endothelium-dependent vasoreactivity, by assessing slightly larger vessels (.150 mm) which may have an effect on downstream blood flow and transmission of pressure to the microcirculation, 21 the endothelium-dependent vasodilator 
Statistical analysis
Continuous variables with no/mild skew were presented as mean + SD; skewed measures as median and inter-quartile ranges. Discrete variables were summarized as frequencies and percentages. Comparisons were made between tertiles using one-way ANOVA for continuous variables with mild skewness, the Kruskal -Wallis rank-sum test for skewed and ordinal variables, and by the Pearson x 2 test for categorical variables. Univariate associations between the FRS, risk factors and the endothelial function measures were assessed by the Spearman correlation coefficient or a rank-sum test. Linear regression models were used to assess the association between the FRS, other risk factors, and the vasomotor function measures. Box -Cox transformations were used for dependent and independent variables to comply with the assumption of multivariate normal data. Variables which were associated with the endpoint at a 0.15 significance level were chosen as model covariates. Multiple linear regression models were fit on each of five multiple imputation data sets; the parameter estimates were then combined and standard errors calculated using SAS (version 9.1.3, SAS Institute Inc., Cary, NC, USA). The partial effect size (henceforth called the 'effect estimate') of the independent continuous variables was scaled to reflect the expected change in the (untransformed) response between the first and third quartiles of the continuous variable.
Results
For the analysis, 1063 patients were included, of which 676 (64%) were female. Baseline characteristics in all patients and by gender are shown in Table 1 . Overall, women were older, and men had a higher FRS and majority were smokers. There were 174 patients without Framingham risk calculated (16%), 262 (25%) with a risk of 1 -2%, 345 (32%) with a risk of 3-5%, 180 (17%) with a risk of 6 -10%, 87 (8%) with a risk of 11 -20%, and only 15 (1.4%) with a risk over 20% (although some more patients had diabetes mellitus or peripheral vascular disease considered a high-risk equivalent). 4 
Endothelium-dependent vasoreactivity
Patients with lower CBF values in response to Ach ( Table 2) were older (P ¼ 0.001) and had a higher prevalence of diabetes mellitus (P ¼ 0.015), hypercholesterolaemia (P ¼ 0.005), elevated BMI (P ¼ 0.002), higher levels of fasting plasma glucose (P , 0.001), elevated glycosylated haemoglobin (P , 0.001), as well as a higher HOMA score (P ¼ 0.005) and higher levels of L-arginine (P ¼ 0.038), but fewer were smokers (P ¼ 0.009). They had a tendency to have a higher FRS, but this did not reach statistical significance ( Figure 1 , P ¼ 0.076). Multivariable analysis (Table 3) showed that a family history of CHD was associated with reduced CBF in men (P ¼ 0.008). Prior use of beta-blockers (%) 290 (27) 203 (30) 87 (22) 0.008
Prior use of angiotensin-converting enzyme inhibitors (%) 145 (14) 81 (12) 64 (17) Endothelium-independent microvascular coronary flow reserve
Patients with reduced CFR (Table 4) were older (P , 0.001), majority were females (P , 0.001), and had a higher FRS (Figure 2 , P ¼ 0.012), hypercholesterolaemia (P ¼ 0.03), a higher mean blood pressure (P , 0.001), a lower eGFR (P ¼ 0.002) and higher levels of BNP (P ¼ 0.009). There was no statistically significant difference in the frequency of prior use of lipid-lowering drugs, calcium channel blockers, or angiotensin-converting enzymes inhibitors among patients in all tertiles. In a multivariable analysis (Table 5) , a higher FRS (P , 0.001), female sex (P , 0.001), and a family history of CHD (P ¼ 0.043) were statistically associated with reduced CFR, while elevated BMI (P , 0.001) was associated with increased CFR.
Overall, there was an inverse relationship ( Figures 1, 2 , and Table 6 ) between the FRS and microcirculatory vasodilator function as assessed by CFR (P ¼ 0.012) and by the CBF (P ¼ 0.076) (as a possible downstream effect on the microcirculation).
Discussion
The results of the current study demonstrate that in a large cohort of patients without obstructive CHD, undergoing invasive coronary angiography and comprehensive assessment of coronary vasomotion, the conventional FRS was independently associated with coronary microcirculatory vasodilator function, specifically with the direct microvascular measurement of CFR. The current study demonstrated that impaired coronary microcirculation function may be present in patients with low to intermediate FRS (,20% 10-year risk) without obstructive CHD.
The current study is the largest series of patients reporting the relationship between risk factors and the invasive evaluation of coronary vasomotor function. 11 This method allowed us to identify the degree of microcirculatory vasomotor function in relation to the FRS and CHD risk factors. Evaluating the contribution of the various coronary risk factors and the applicability of the FRS to early atherosclerosis is clinically important because primary prevention protocols rely on risk assessment. 23 Our findings show that even within a group of patients considered to be at low to intermediate risk of developing CHD, the FRS was still higher in the group of patients with abnormal CFR. Thus, our study demonstrates the usefulness of FRS in individuals with impaired microcirculatory vasodilator function even at the early stage of CHD. However, as a 1-2% difference in FRS may not necessarily translate into practical recommendation for the individual patient, it is possible that the assessment of coronary vasomotor function and/or the integration of new parameters to the current FRS may improve the diagnosis of early coronary atherosclerosis and potentially identify the patients at risk for adverse cardiovascular events. The presence of systemic conventional CHD risk factors may indeed serve as a milieu for the development of abnormal microcirculatory vasomotor function. This has been already shown before for several risk factors. 24 Those risk factors may play a role in the initiation and progression of early atherosclerosis by instigating oxidative stress and inflammation, and the first stage of the disease may actually be a functional abnormality. Structural abnormality affecting the microcirculation (e.g. arteriolar remodelling) cannot be excluded but this cannot be assessed in vivo with current imaging techniques. It is possible that the pathophysiology of coronary atherosclerosis at the very early stages of disease involves the microcirculation, and only later epicardial involvement is apparent. This may explain why the FRS, which incorporates established risk factors, is still applicable at the early stages of CHD, but also why conventional (epicardial) coronary arteriography is of limited value.
In our study, other established risk factors (such as hsCRP) had no significant association with the functional abnormalities (abnormal CFR) in early atherosclerosis. The lack of independent correlation between the laboratory markers assessed and microcirculatory vasomotor function may suggest that other novel markers such as Lp-PLA2 or asymmetric dimethyl-arginine, which may be more specific to the vascular wall and involved in the process of vascular injury and repair, may be used as a risk marker at the early stages of the disease. 25, 26 Coronary microvascular dysfunction was shown to be associated with myocardial perfusion defects when using either myocardial scintigraphy or magnetic resonance imaging. 19, 27 Our findings now provide further insight into the link between CHD risk factors and microcirculatory dysfunction which may lead to adverse cardiovascular events. 24 The observation that risk factors . ............ ............ ............ ............ ........... ............ ............ ............ ........... ............ ............ ............ ........... ............ . ..... 36 (11) 28 (8) 22 (6) it is not uncommon for patients who present with acute coronary syndromes to have normal epicardial coronary arteries at angiography. 28, 29 Moreover, recent studies demonstrate the prevalence and the prognostic significance of the response to intracoronary Ach in patients with acute coronary syndromes. 30 Our findings suggest that microvascular dysfunction may be the underlying mechanism of these events and that further assessment of microvascular function, and especially the CFR, might reveal the underlying source for symptoms, and help to assess prognosis in these cases. While our focus was the coronary vasculature, previous evaluations of the peripheral endothelial function yielded conflicting results. It has been suggested that lipids, BMI and smoking are important determinants of vascular reactivity and that the FRS was predictive of agonist-stimulated, endothelium-dependent vasodilation and basal nitric oxide release. In patients with established (and stable) CHD, only age and diabetes mellitus were found to be associated with (peripheral) endothelial dysfunction. 31 The association between a positive family history of CHD and lower microcirculatory vasodilator function in our study (especially in men) is also of interest. Although the exact mechanism is unclear, a family history of CHD is an established and important CHD risk factor, and our findings suggest that a positive family history of CHD may actually represent an inherited physiological trait that may later lead to overt symptoms and future events. 32 Interestingly, among the risk factors evaluated, smoking history by itself was not associated with abnormal CFR (Table 4) , but paradoxically was a univariate associate of greater CBF ( Table 2) , which is in contradiction to endothelial dysfunction of epicardial arteries or microvascular dysfunction previously reported in smokers. 17, 20 
Limitations
The main limitation of the current study is the inherent deficiency of most of clinically oriented case-series trials which is ascertainment bias. Additionally, two-thirds of our patients were female. However, microvascular dysfunction is more important in women and its prognostic value has been demonstrated. 33 -35 Additional limitation is that in order to be included in the study, patients had to be referred to coronary angiography. Therefore, patients in the current study were more likely to be a cohort of selected patients with symptoms or positive stress tests, therefore with a higher likelihood to have coronary microvascular dysfunction when compared with the unselected group with risk factors or with asymptomatic patients. Relation between coronary risk factors and endothelial dysfunction
Conclusion
In conclusion, the current study demonstrates that the FRS, female sex, and a family history of CHD were associated with impaired coronary microvascular function in patients at low to intermediate risk without obstructive CHD. Our study provides insights into the inter-relationships between traditional risk factors, FRS and coronary microcirculatory vasomotor function in a large group of patients with indications for coronary angiography but without obstructive coronary artery disease. Our findings also suggest that evaluation of the microcirculatory vasomotor function may help to better define the group of patients in whom the severity of early CHD may actually be greater than appreciated by their FRS.
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